サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1134962

感染症体外診断薬の世界市場規模調査＆予測、製品別、用途別、技術別、地域別分析、2022-2029年

Global Infectious Disease In Vitro Diagnostics Market Size study & Forecast, by Product, by Application, by Technology and Regional Analysis, 2022-2029
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
感染症体外診断薬の世界市場規模調査＆予測、製品別、用途別、技術別、地域別分析、2022-2029年
出版日: 2022年10月08日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

感染症体外診断薬とは、静脈や指から採取した血液、鼻の中や喉の奥から採取した粘液など、人体から採取した試料を用いて行う検査の一種です。

感染症体外診断薬は、個人の体内に存在するさまざまな感染症を診断するために使用されます。高齢者人口の増加、感染症の発生率の上昇、早期診断に対する意識の高まりが、世界的に市場需要を急拡大させている主な要因となっています。

世界保健機関（WHO）によると、2010年に5億2,400万人以上と推定された世界の老年人口は、2050年までに約20億人に増加すると予想されています。それに伴い、老年人口の増加は、免疫力の低下により様々な感染症に罹患しやすくなり、感染症体外診断薬市場の成長を世界的に加速させています。また、PoC施設に対する需要の高まりや、研究開発活動への資金提供の増加は、予測期間中に市場成長のための様々な有利な機会を生み出しています。しかし、IVD検査のコストが高いことが、2022年から2029年の予測期間を通じて市場成長を阻害しています。

世界の感染症体外診断薬市場の調査において考慮された主要地域は、アジア太平洋地域、北米、欧州、中南米、世界のその他の地域です。北米は、様々な検査や早期診断の実施による疾病監視の重要性の高まり、主要企業の地理的拡大、地域全体における良好な規制枠組みの存在により、収益の点でこの分野を支配しています。一方、アジア太平洋地域は、予測期間中に大きく成長することが予想されます。人口の増加、対象疾患や感染症の有病率の上昇、ヘルスケア支出の増加といった要因が、今後数年間における同地域の市場成長を後押ししています。

本レポートに含まれる主な市場参入企業は以下の通りです。

  • QIAGEN
  • bioMerieux SA
  • F. Hoffmann-La Roche, Ltd.
  • Hologic, Inc.（Gen-Probe）
  • Abbott
  • Quidel Corp.
  • Siemens Healthineers AG
  • Bio-Rad Laboratories, Inc.
  • Danaher Corp.
  • OraSure Technologies, Inc.

本調査の目的は、近年における様々なセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することにあります。本レポートは、調査対象国における産業の質的・量的な側面を取り入れることを意図しています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細な情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。市場の詳細なセグメントとサブセグメントを以下に説明します。

製品別

機器

試薬

ソフトウェア

アプリケーション別

呼吸器系ウイルス

結核・薬剤耐性結核

消化器系パネルテスト

HIV

肝炎

COVID-19

その他

技術別

イムノアッセイ

分子生物学的診断法

その他

微生物学

地域別

北米

米国

カナダ

欧州

英国

ドイツ

フランス

スペイン

イタリア

その他欧州

アジア太平洋地域

中国

インド

日本

オーストラリア

韓国

その他アジア太平洋

ラテンアメリカ

ブラジル

メキシコ

世界のその他の地域

目次

第1章 エグゼクティブサマリー

  • 市場スナップショット
  • 世界・セグメント別市場推定・予測、2019年～2029年
    • 感染症体外診断薬市場：地域別、2019年～2029年
    • 感染症体外診断薬市場（製品別）：2019-2029年
    • 感染症体外診断薬市場：用途別、2019-2029年
    • 感染症体外診断薬市場：技術別、2019年～2029年
  • 主な動向
  • 調査手法
  • 調査前提条件

第2章 感染症体外診断薬の世界市場の定義と範囲

  • 調査の目的
  • 市場の定義と範囲
    • 調査対象範囲
    • 産業の進化
  • 調査対象年
  • 通貨換算レート

第3章 感染症体外診断薬の世界市場力学

  • 感染症体外診断薬市場のインパクト分析（2019年～2029年）
    • 市場促進要因
      • 老年人口の増加
      • 対象感染症の発生率の上昇
    • 市場の課題
      • 体外診断用医薬品の高コスト
    • 市場機会
      • PoC施設に対する需要の高まり
      • 研究開発活動への資金提供の増加

第4章 感染症体外診断薬の世界市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
  • PEST分析
    • 政治的
    • 経済的
    • 社会的
    • 技術的
  • 投資採用モデル
  • アナリストの結論・提言
  • トップ投資機会
  • 主要成功戦略

第5章 リスク評価：COVID-19のインパクト

  • COVID-19が業界に与える全体的な影響の評価
  • COVID-19以前とCOVID-19以後の市場シナリオ

第6章 感染症体外診断薬の世界市場：製品別

  • 市場スナップショット
  • 感染症体外診断薬の世界市場：製品別、性能-ポテンシャル分析
  • 感染症体外診断薬の世界市場、製品別推定・予測、2019～2029年
  • 感染症体外診断薬市場、サブセグメント分析
    • 器具類
    • 試薬
    • ソフトウェア

第7章：感染症体外診断薬の世界市場：アプリケーション別

  • 市場スナップショット
  • 感染症体外診断薬の世界市場：アプリケーション別性能-ポテンシャル分析
  • 感染症体外診断薬の世界市場、アプリケーション別推定・予測、2019-2029年
  • 感染症体外診断薬市場、サブセグメント分析
    • 呼吸器系ウイルス
    • 結核と薬剤耐性結核
    • 消化器系パネル検査
    • HIV
    • 肝炎
    • COVID-19
    • その他

第8章 感染症体外診断薬の世界市場：技術別

  • 市場スナップショット
  • 感染症体外診断薬の世界市場：技術別、性能、ポテンシャル分析
  • 感染症体外診断薬の世界市場、技術別推定・予測、2019-2029年
  • 感染症体外診断薬市場、サブセグメント分析
    • 免疫測定法
    • 分子生物学的診断法
    • その他
    • 微生物学

第9章 感染症体外診断薬の世界市場：地域別分析

  • 感染症体外診断薬市場、地域別市場スナップショット
  • 北米
    • 米国
      • 製品別の推定・予測、2019-2029年
      • アプリケーション別の推定・予測、2019年～2029年
      • 技術別の推定・予測、2019年～2029年
    • カナダ
  • 欧州の感染症体外診断薬市場のスナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他の欧州地域
  • アジア太平洋地域の感染症体外診断薬市場のスナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの感染症体外診断薬市場スナップショット
    • ブラジル
    • メキシコ
  • 世界のその他の地域

第10章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • QIAGEN
      • 主な情報
      • 概要
      • 財務（データの入手が可能な場合）
      • 製品概要
      • 最近の開発状況
    • bioMerieux SA
    • F. Hoffmann-La Roche, Ltd.
    • Hologic, Inc.（Gen-Probe）
    • Abbott
    • Quidel Corp.
    • Siemens Healthineers AG
    • Bio-Rad Laboratories, Inc.
    • Danaher Corp.
    • OraSure Technologies, Inc.

第11章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Infectious Disease In Vitro Diagnostics Market, report scope
  • TABLE 2. Global Infectious Disease In Vitro Diagnostics Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Infectious Disease In Vitro Diagnostics Market estimates & forecasts by Product 2019-2029 (USD Billion)
  • TABLE 4. Global Infectious Disease In Vitro Diagnostics Market estimates & forecasts by Application 2019-2029 (USD Billion)
  • TABLE 5. Global Infectious Disease In Vitro Diagnostics Market estimates & forecasts by Technology 2019-2029 (USD Billion)
  • TABLE 6. Global Infectious Disease In Vitro Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Infectious Disease In Vitro Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Infectious Disease In Vitro Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Infectious Disease In Vitro Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Infectious Disease In Vitro Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Infectious Disease In Vitro Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Infectious Disease In Vitro Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Infectious Disease In Vitro Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Infectious Disease In Vitro Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. Global Infectious Disease In Vitro Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 17. U.S. Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. U.S. Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 20. Canada Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. Canada Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 23. UK Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. UK Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 26. Germany Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. Germany Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 29. France Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. France Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 32. Italy Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Italy Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 35. Spain Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. Spain Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 38. RoE Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. RoE Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 41. China Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. China Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 44. India Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. India Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 47. Japan Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. Japan Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 50. South Korea Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. South Korea Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 53. Australia Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. Australia Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. RoAPAC Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 59. Brazil Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Brazil Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 62. Mexico Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. Mexico Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 65. RoLA Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. RoLA Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Infectious Disease In Vitro Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 68. Row Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. Row Infectious Disease In Vitro Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Infectious Disease In Vitro Diagnostics Market
  • TABLE 71. List of primary sources, used in the study of global Infectious Disease In Vitro Diagnostics Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Infectious Disease In Vitro Diagnostics Market, research methodology
  • FIG 2. Global Infectious Disease In Vitro Diagnostics Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Infectious Disease In Vitro Diagnostics Market, key trends 2021
  • FIG 5. Global Infectious Disease In Vitro Diagnostics Market, growth prospects 2022-2029
  • FIG 6. Global Infectious Disease In Vitro Diagnostics Market, porters 5 force model
  • FIG 7. Global Infectious Disease In Vitro Diagnostics Market, pest analysis
  • FIG 8. Global Infectious Disease In Vitro Diagnostics Market, value chain analysis
  • FIG 9. Global Infectious Disease In Vitro Diagnostics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Infectious Disease In Vitro Diagnostics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Infectious Disease In Vitro Diagnostics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Infectious Disease In Vitro Diagnostics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Infectious Disease In Vitro Diagnostics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Infectious Disease In Vitro Diagnostics Market, regional snapshot 2019 & 2029
  • FIG 15. North America Infectious Disease In Vitro Diagnostics Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Infectious Disease In Vitro Diagnostics Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia Pacific Infectious Disease In Vitro Diagnostics Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Infectious Disease In Vitro Diagnostics Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Infectious Disease In Vitro Diagnostics Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Infectious Disease In Vitro Diagnostics Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Infectious Disease In vitro diagnostic (IVD) is a type of test that is performed on samples taken from the human body, such as blood taken from a vein or fingerstick or swabs of mucus from inside the nose or back of the throat. Infectious Disease In vitro diagnostic is used to diagnose various infectious diseases that are present in an individual's body. The increasing geriatric population, rising incidences of target infections, coupled with the growing awareness about early diagnosis are the primary factors that are burgeoning the market demand across the globe.

As per the World Health Organization (WHO), the global geriatric population, which was estimated to be over 524 million in 2010, is expected to increase to nearly 2 billion by 2050. Accordingly, the increasing geriatric population is more prone to get affected by a wide range of infectious diseases due to low immunity, which is accelerating the growth of the Infectious Disease In Vitro Diagnostics Market globally. In addition, growing demand for PoC facilities, as well as increasing funding for R&D activities are creating various lucrative opportunities for market growth over the forecasting years. However, the high cost of IVD tests stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Infectious Disease In Vitro Diagnostics Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the space in terms of revenue, owing to the rising emphasis on disease surveillance by conducting various tests and early diagnostics, geographic expansion of key players, along with the presence of favorable regulatory framework across the region. Whereas, Asia Pacific is expected to grow significantly during the forecast period. Factors such as increasing population, rising prevalence of target diseases and infections, and rising healthcare expenditure are bolstering regional market growth in the forthcoming years.

Major market players included in this report are:

QIAGEN

bioMerieux SA

F. Hoffmann-La Roche, Ltd.

Hologic, Inc. (Gen-Probe)

Abbott

Quidel Corp.

Siemens Healthineers AG

Bio-Rad Laboratories, Inc.

Danaher Corp.

OraSure Technologies, Inc.

Recent Developments in the Market:

  • In January 2020, Quest Diagnostics entered into a collaborative agreement with Memorial Hermann Health System to offer enhanced, high-quality, cost-efficient, and innovative diagnostic services for 21 hospital laboratories across the Huston region. The objective of this initiative is geographical expansion.
  • In June 2022, Eurobio Scientific declared the introduction of two novel tests for SARS-CoV-2 (for variants Omicron BA.2, BA.1, and BA.4/BA.5) and Monkeypox in France.

Global Infectious Disease In Vitro Diagnostics Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Product, Application, Technology, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Instruments

Reagents

Software

By Application:

Respiratory Virus

TB and Drug-resistant TB

Gastro-intestinal Panel Testing

HIV

Hepatitis

COVID-19

Others

By Technology:

Immunoassay

Molecular Diagnostics

Others

Microbiology

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Infectious Disease In Vitro Diagnostics Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Infectious Disease In Vitro Diagnostics Market, by Product, 2019-2029 (USD Billion)
    • 1.2.3. Infectious Disease In Vitro Diagnostics Market, by Application, 2019-2029 (USD Billion)
    • 1.2.4. Infectious Disease In Vitro Diagnostics Market, by Technology, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Infectious Disease In Vitro Diagnostics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Infectious Disease In Vitro Diagnostics Market Dynamics

  • 3.1. Infectious Disease In Vitro Diagnostics Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing geriatric population
      • 3.1.1.2. Rising incidences of target infections
    • 3.1.2. Market Challenges
      • 3.1.2.1. High cost of IVD tests
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growing demand for PoC facilities
      • 3.1.3.2. Increasing funding for R&D activities

Chapter 4. Global Infectious Disease In Vitro Diagnostics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Infectious Disease In Vitro Diagnostics Market, by Product

  • 6.1. Market Snapshot
  • 6.2. Global Infectious Disease In Vitro Diagnostics Market by Product, Performance - Potential Analysis
  • 6.3. Global Infectious Disease In Vitro Diagnostics Market Estimates & Forecasts by Product, 2019-2029 (USD Billion)
  • 6.4. Infectious Disease In Vitro Diagnostics Market, Sub Segment Analysis
    • 6.4.1. Instruments
    • 6.4.2. Reagents
    • 6.4.3. Software

Chapter 7. Global Infectious Disease In Vitro Diagnostics Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Infectious Disease In Vitro Diagnostics Market by Application, Performance - Potential Analysis
  • 7.3. Global Infectious Disease In Vitro Diagnostics Market Estimates & Forecasts by Application, 2019-2029 (USD Billion)
  • 7.4. Infectious Disease In Vitro Diagnostics Market, Sub Segment Analysis
    • 7.4.1. Respiratory Virus
    • 7.4.2. TB and Drug-resistant TB
    • 7.4.3. Gastro-intestinal Panel Testing
    • 7.4.4. HIV
    • 7.4.5. Hepatitis
    • 7.4.6. COVID-19
    • 7.4.7. Others

Chapter 8. Global Infectious Disease In Vitro Diagnostics Market, by Technology

  • 8.1. Market Snapshot
  • 8.2. Global Infectious Disease In Vitro Diagnostics Market by Technology, Performance - Potential Analysis
  • 8.3. Global Infectious Disease In Vitro Diagnostics Market Estimates & Forecasts by Technology, 2019-2029 (USD Billion)
  • 8.4. Infectious Disease In Vitro Diagnostics Market, Sub Segment Analysis
    • 8.4.1. Immunoassay
    • 8.4.2. Molecular Diagnostics
    • 8.4.3. Others
    • 8.4.4. Microbiology

Chapter 9. Global Infectious Disease In Vitro Diagnostics Market, Regional Analysis

  • 9.1. Infectious Disease In Vitro Diagnostics Market, Regional Market Snapshot
  • 9.2. North America Infectious Disease In Vitro Diagnostics Market
    • 9.2.1. U.S. Infectious Disease In Vitro Diagnostics Market
      • 9.2.1.1. Product breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Application breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. Technology breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Infectious Disease In Vitro Diagnostics Market
  • 9.3. Europe Infectious Disease In Vitro Diagnostics Market Snapshot
    • 9.3.1. U.K. Infectious Disease In Vitro Diagnostics Market
    • 9.3.2. Germany Infectious Disease In Vitro Diagnostics Market
    • 9.3.3. France Infectious Disease In Vitro Diagnostics Market
    • 9.3.4. Spain Infectious Disease In Vitro Diagnostics Market
    • 9.3.5. Italy Infectious Disease In Vitro Diagnostics Market
    • 9.3.6. Rest of Europe Infectious Disease In Vitro Diagnostics Market
  • 9.4. Asia-Pacific Infectious Disease In Vitro Diagnostics Market Snapshot
    • 9.4.1. China Infectious Disease In Vitro Diagnostics Market
    • 9.4.2. India Infectious Disease In Vitro Diagnostics Market
    • 9.4.3. Japan Infectious Disease In Vitro Diagnostics Market
    • 9.4.4. Australia Infectious Disease In Vitro Diagnostics Market
    • 9.4.5. South Korea Infectious Disease In Vitro Diagnostics Market
    • 9.4.6. Rest of Asia Pacific Infectious Disease In Vitro Diagnostics Market
  • 9.5. Latin America Infectious Disease In Vitro Diagnostics Market Snapshot
    • 9.5.1. Brazil Infectious Disease In Vitro Diagnostics Market
    • 9.5.2. Mexico Infectious Disease In Vitro Diagnostics Market
  • 9.6. Rest of The World Infectious Disease In Vitro Diagnostics Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. QIAGEN
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. bioMerieux SA
    • 10.2.3. F. Hoffmann-La Roche, Ltd.
    • 10.2.4. Hologic, Inc. (Gen-Probe)
    • 10.2.5. Abbott
    • 10.2.6. Quidel Corp.
    • 10.2.7. Siemens Healthineers AG
    • 10.2.8. Bio-Rad Laboratories, Inc.
    • 10.2.9. Danaher Corp.
    • 10.2.10. OraSure Technologies, Inc.

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption